RBSH
Inspyr Therapeutics Inc

1,505
Mkt Cap
$0.00
Volume
137.00
52W High
$0.0002
52W Low
$0.00
Price
$0.0001
RBSH Fundamentals
Open
$0.0001
50D MA
$0.0001
Beta
59.26
Avg. Volume
4,722.29
Loading...
Loading...
Rebus Holdings, Inc. is a pharmaceutical company engaged in the research and development of novel therapeutics for the treatment of cancer. Its product pipeline includes Mipsagargin, a dual A2A/A2B antagonist, an A2A antagonist, an A2B antagonist, and an A2A agonist. The company was founded by Craig A. Dionne, John T. Issacs, and Samuel R. Denmeade on November 21, 2003 and is headquartered in Westlake Village, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Rebus Holdings Inc?
What is the 52-week high for Rebus Holdings Inc?
What is the 52-week low for Rebus Holdings Inc?
What is Rebus Holdings Inc stock price today?
What is the 50-day moving average of Rebus Holdings Inc?

Latest RBSH News

View
No RBSH news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.